Up to now there is no specific treatment targeting the ultimate cause of in
terstitial cystitis (IC), since its pathogenesis and etiology are still unk
nown. Most studies focussing on oral medication have not been randomized,do
uble-blinded or placebo-controlled. Numerous case reports and intent-to-tre
at trials are lacking a systematic approach and do not meet evidence-based
medicine criteria. Consequently there is as yet no standard oral therapy av
ailable for the treatment of IC.
However, only a few oral substances have shown a potential to improve sympt
oms such as frequency and pain. The best results were obtained from manothe
rapeutic use of pentosanpolysulfate, amitriptylin and hydroxycin. The true
benefit of these substances alone should be compared to analgesics and anti
cholinergics in the course of controlled clinical trials.